(HealthDay News) — Disadvantaged populations and those living outside of a comprehensive cancer center’s main catchment area have higher odds of receiving a diagnosis of late-stage cancer, according ...

Quantifying the density of tubulointerstitial macrophage infiltration in kidney biopsy samples improves prediction of response to immunosuppression in patients with lupus nephritis. Macrophage ...

In children with lupus nephritis, neurological manifestations at the time of kidney biopsy, age, and eGFR predicted greater risk of CKD progression. Investigators have identified predictors of chronic ...

Palliative care for men with prostate cancer in the US is improving but remains low at 5.3%, with utilization disparities by race and insurance type. Palliative care utilization among men with ...

An analysis of bladder cancer death trends from 2000 to 2020 found the biggest decline in urban areas, especially during 2016 to 2020, and no significant change in rural areas. Bladder cancer deaths ...

Olaparib monotherapy demonstrates clinical benefit despite use in later lines of therapy in a real-world study of patients with mCRPC and human recombinant repair gene mutations. Several lines of ...

Compared with placebo, men taking metformin or ACE inhibitors concomitantly with apalutamide for nonmetastatic castration-resistant had significantly longer metastasis-free survival. Concomitant ...

Real-world data show that abiraterone is significantly associated with a 26% higher risk for major adverse cardiovascular events compared with enzalutamide in men with metastatic castration-resistant ...

Using a subsequent ARPI after progression on darolutamide plus ADT and docetaxel in the metastatic hormone-sensitive setting does not provide a survival advantage compared with using subsequent ...

Men treated with darolutamide for nonmetastatic castration-resistant prostate cancer who achieve a PSA level less than 0.2 ng/mL vs higher levels have a decreased risk for radiologic progression.

A study identified trends in GLP-1 agonist discontinuation. (HealthDay News) — Specific demographic, clinical, and financial characteristics are associated with glucagon-like peptide 1 (GLP-1) ...

A validated sexual health survey identifies how women's sex lives are affected by prostate cancer in their male partners. (HealthDay News) — The Sexual Concerns In Partners of Patients with Prostate ...